...
首页> 外文期刊>Journal of Stem Cells and Regenerative Medicine >Depletion of Alloreactive T cells for Tolerance Induction in a Recipient of Kidney and Hematopoietic Stem Cell Transplantations
【24h】

Depletion of Alloreactive T cells for Tolerance Induction in a Recipient of Kidney and Hematopoietic Stem Cell Transplantations

机译:肾脏和造血干细胞移植受者中同种异体反应性T细胞的耗竭诱导诱导枯竭。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The present case report represents a successful attempt to induce transplantation tolerance to organ allograft by combined administration of donor hematopoietic cells and kidney based on in vivo deletion of alloreactive host-vsgraft and graft-vs-host alloreactive T cells following nonmyeloablative conditioning. We were able to induce mixed and eventually full donor chimerism and tolerance of kidney allograft in a 15-year-old male with ESRD after cisplatin treatment and autologous HSCT for mediastinal germ cell tumor. Our approach to induce tolerance was based on preferential depletion of alloreactive T cells induced by exposure to donor’s alloantigens and administration of cyclophosphamide at day 2 & day 3 after stem cells infusion. Additional non-specific immunosuppression as part of the conditioning included exposure to 2 fractions of TLI, treatment with alemtuzumab (monoclonal anti-CD52) and short-term conventional IS treatment to avoid early graft loss, due to request of IRB. Using this approach, with rapid tapering of all conventional IS treatment the patient maintains good renal functions without evidence of both acute and chronic rejection for 25 months off all medications.
机译:本病例报告代表了基于非清髓性调节后体内对同种异体反应性宿主细胞和同种对同体异体反应性T细胞的体内缺失,通过联合施用供体造血细胞和肾脏诱导对器官同种异体移植耐受的成功尝试。在顺铂治疗和自体HSCT治疗纵隔生殖细胞肿瘤后,我们能够诱导15岁男性ESRD的混合供体嵌合并最终达到完全供体嵌合和肾移植的耐受性。我们诱导耐受性的方法是基于同种异体性T细胞的优先消耗,所述异种性T细胞是由于暴露于供体的同种抗原而引起的,并且在干细胞输注后第2天和第3天给予了环磷酰胺。作为调理的一部分,其他非特异性免疫抑制包括暴露于TLI的2部分,使用alemtuzumab(单克隆抗CD52)治疗以及短期常规IS治疗以避免早期移植物丢失(由于IRB的要求)。使用这种方法,在所有常规IS治疗迅速缩小的情况下,患者在维持所有药物治疗25个月的时间内,都不会出现急性和慢性排斥反应的情况,保持了良好的肾功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号